Ten minutes of complete cerebral ischemia was produced in 18 dogs by temporary ligation of the aorta and venae cavae. Dogs were randomly assigned to one of three groups. A bolus dose of 10 f,Lg kg -I nimodi pine, a dihydropyridine calcium entry blocker. followed by a constant infusion of I f,Lg kg -I min -1 was given at 15. 30, or 60 min post ischemia. Cerebral blood t10w and me tabolism were measured for 2 h postischemia. Delayed treatment with nimodipine ameliorated or reversed the cerebral hypoperfusion that routinely occurs after com plete ischemia. In the groups treated at 15 and 30 min.
With restoration of blood flow following an insult of complete cerebral ischemia, there is a transient 10-to 20-min period of reactive hyperemia followed by a prolonged period of hypoperfusion. The length of this seems to depend on the duration of the isch emia but has been reported to be at least 6 h in dogs (Steen et aI., 1978) , primates (Ginsberg and Myers, 1972) , and humans and less than 24 h in humans (Beckstead et aI. , 1978) . During this time the global CBF in dogs is �25 ml min-1 100 g-l (Steen et aI. , 1978) and may be inadequate to supply the nutrient and oxygen demands of the cells, thereby pro ducing a state of incomplete ischemia in some areas. In support of this, histopathologic changes tend to occur symmetrically in the distribution of distal arterial perfusion zones. indicative of incom plete rather than complete cerebral ischemia (Steen et aI. , 1985) . pine, CBF immediately increased and was maintained above 50 ml min -1 100 g -1 for the remainder of the study.
Once treatment with nimodipine was begun. CBF was ap proximately double that of an untreated group. Changes in CBF ret1ected changes in cerebrovascular resistance.
Nimodipine had no effect on cerebral metabolism. Since the postischemic hypoperfusion state is believed to con tribute to the ultimate neurologic damage following com plete ischemia. treatment with nimodipine. even if de layed up to 60 min. may improve the outcome. Key Words: Calcium entry blocker-Cerebral blood t1ow
Cerebral ischemia-Cerebral metabolism-Cerebral protection-Nimodipine.
We have demonstrated that nimodipine, a dihy dropyridine calcium entry blocker with cerebrovas cular specificity, ameliorates the postischemic hy poperfusion state and may improve neurologic re covery if given before or immediately after 10 min of complete cerebral ischemia in dogs (Steen et aI., 1983 (Steen et aI., , 1984 . In primates we demonstrated that ni modipine given 5 min after 17 min of ischemia im proves the outcome (Steen et a\. , 1985) . This sug gests that the delayed hypoperfusion state may contribute to the ultimate neurologic damage. How ever, the reality of clinical practice is such that im mediate postresuscitation treatment with nimodi pine following complete cerebral ischemia from cardiac arrest may not be possible. Delays of �60 min might occur between the ischemic event and initiation of specific therapy.
The purpose of the present study was to prolong the interval between ischemia and treatment to de termine whether nimodipine might still reverse or ameliorate the hypoperfusion state. We measured the effects of nimodipine given 15, 30, or 60 min following ischemia on cerebral blood flow and me tabolism in dogs exposed to 10 min of complete ce rebral ischemia.
MATERIALS AND METHODS
The methodology involved in this canine model of complete ischemia was approved by the Animal Research Committee of the Mayo Clinic.
Eighteen unmedicated fasting adult mongrel dogs weighing 9-16 kg were used to study the effect of de layed treatment with nimodipine on CBF, cerebral vas cular resistance expressed as an index (CYRIl. and cere bral metabolism following 10 min of complete cerebral ischemia. The results were compared with those pre viously established for an untreated group (Steen et aI., 1978) .
Anesthesia was induced and maintained throughout the surgical procedure with 0.8 % end-expired halothane (measured by a Perkin Elmer mass spectrometer). At the completion of the study, the skull and dura overlying the cerebral hemispheres were excised and cortical biopsies were taken (Kramer et al., 1968) and prepared for analysis (Folbergrova et aI., 1972) . The cere bral tissue was analyzed by enzymatic fluorometric tech niques for phosphocreatine (P Cr), ATP, ADP, AMP, lac tate, and pyruvate (Lowry et aI., 1964; Lowry and Pas soneau, 1972) . The energy state of the brain was expressed as the energy charge equal to [(ATP) + 0.5 (ADP)]/[(ATP) + (ADP) + (AMP)] (Atkinson, 1968 
RESULTS
During the preischemic control period, there were no significant differences between the three groups in MAP, ICP, arterial blood chemistries, or sagittal sinus Pco2. While most of the arterial blood gases were similar among the three groups pre ischemia, the Pco2 and pH of the group treated at 60 min were significantly different from those of the group treated at 30 min. However, these values re mained within the normal physiologic range so that CBF was unaffected (Table I) . Preischemic values were similar to those previously obtained in an un treated group (Steen et aI., 1978) . There were no significant differences in the arterial blood gases among the three groups post ischemia. In all groups there was a significant increase in Paco2 at I min postischemia due to the accumulation of CO2 and lactate during the ischemic period. These changes had returned to normal by 10 min postischemia. Postischemia and during the infusion of nimodi pine, MAP was significantly less than preischemia but was maintained at all times at >70 mm Hg. ICP increased transiently in all groups during the post ischemic hyperemic phase, but decreased to normal by 20 min postischemia.
There were no significant differences in CBF among the groups preischemia (Fig. 1) . Immedi ately postischemia in all groups, there was a tran sient increase in CBF, which lasted 5-10 min, fol lowed by a rapid decrease in CBF, which was sig nificantly below the preischemic level by 30 min except in the group treated with nimodipine at 15 min. This was followed by a more gradual decline in CBF in the remaining two groups until treatment 
FIG. 1. CBF preischemia and after 10 min of complete cere bral ischemia in dogs. In the three treatment groups. nimodi pine (10 fLg kg-1 followed by an infusion at 1 fLg kg-1 min- with nimodipine was instituted. In the group treated at 15 min postischemia, CBF continued to decline but remained at all times at >60 ml min -1 100 g -I. In the group treated at 30 min, CBF was maintained at �60 ml min-I 100 g-I throughout the remainder of the study.
The effect of nimodipine on the CBF was most noticeable when given 60 min postischemia. Fol lowing the transient hyperperfusion, there was a progressive decline in CBF to 37 ± 4 ml min -1 100 g-I at 60 min. Following the bolus doses of nimodi pine, CBF immediately increased to 48 ± 7 ml min -1 100 g-I and then during the nimodipine infu sion gradually increased over the next 60 min so that it was maintained at or above 50 ml min -I 100 g-I (Fig. I) .
The changes in CBF mirrored the changes in CVRI (Fig. 2) . In all three treatment groups, fol lowing a transient decrease in this parameter (during the hyperemic phase), CVRI increased pro gressively until treatment with nimodipine was begun. In the group treated at 15 min, CVRI was maintained at approximately the preischemic level.
In the group treated at 30 min, CVRI decreased with nimodipine from 1. 6 mm Hg ml-I min -I 100 g-I and was maintained at � 1. 2 mm Hg ml-I min -I 100 g-l. Likewise, in the group treated at 60 min, nimodipine caused CVRI to decrease from 2. 4 to 1. 3 mm Hg ml-I min-I 100 g-I where it was maintained.
Delayed nimodipine treatment had no effect on cerebral oxygen metabolism. Immediately fol lowing ischemia there was a transient decrease in CMR02 followed by an increase to � 78% of the preischemic value where it was maintained (Fig. 3) .
In all groups the EEG became isoelectric within 27 ± 2 s of circulatory arrest. There was return of EEG activity 21 ± 2 min post ischemia.
There were no significant differences in levels of the cerebral metabolites among the nimodipine treated groups (Table 2) . However, in all groups the levels of the adenine nucleotides were decreased from normal (only the 60-min nimodipine group was significantly less than normal) while the PCr concentration, glucose concentration, and lactate pyruvate ratio were increased. The glucose con centration was significantly increased in the 60-min nimodipine group while the lactate-pyruvate ratio was significantly increased in all groups. These changes are similar to those observed in the pre viously reported nimodipine studies (Steen et ai. , 1983 (Steen et ai. , , 1984 .
DISCUSSION
When the CBF decreases below a certain threshold (�20 ml min-I 100 g-I), cerebral func tion becomes impaired (Heiss et ai. , 1976; Mora wetz et ai. , 1978; Jones et ai. , 198 1) . A further de crease in CBF to below a critical limit of 8-10 ml min -I 100 g-I will lead to cell death and therefore irreversible functional impairment. With restora-
FIG. 3. Cerebral oxygen metabolism preischemia and after 10 min of complete cerebral ischemia in dogs. In the three treatment groups, nimodipine (10 f,Lg kg-1 followed by an in fusion at 1 f,Lg kg -1 min -1) was instituted at 15, 30, or 60 min.
Each symbol represents the mean value for six dogs. There was no difference in CMR02 among the untreated or treat ment groups.
tion of blood flow following complete cerebral isch emia, there is a transient 10-to 20-min period of hyperperfusion followed by a prolonged period of hypoperfusion during which the global CBF in dogs is �25 ml min-I 100 g-l (Steen et ai. , 1978) . How ever, this CBF may be inhomogeneous with areas of severely decreased or no perfusion and areas of normal or hyperperfusion (Kagstrom et ai. , 1983) .
Histopathologic changes, characterized primarily by early ischemic neuronal change, ischemic neu ronal necrosis, and infarction, are predictably most noticeable in gray matter. These are symmetric and follow the distribution of distal arterial perfusion zones consistent with a form of incomplete isch emia that can occur only during the postischemic hypoperfusion period (Steen et ai. , 1985) . This sug gests that the structure of the brain most vulnerable to complete ischemia may be the cerebral vascula ture per se. Therefore, adequate reperfusion of the brain following ischemia may be critical in brain re suscitation. Nimodipine has been shown to signifi cantly increase CBF especially in the cerebral cor tices, hippocampus, hypothalamus, and most tha lamic nuclei (Mohamed et ai., 1985) . Nimodipine not only increases global CBF, but it has been shown to produce a redistribution of blood flow in an infarcted hemisphere, leading to an increase in CBF in ischemic areas and a decrease in hyperemic areas (Symon et ai. , 1982) .
Calcium seems to play a pivotal role in the pro duction of the delayed hypoperfusion state that follows a period of complete cerebral ischemia (Siesj6, 1984) . Complete ischemia causes a rapid decay of the normal calcium ion gradient across cell membranes. There is a rapid depletion of ATP stores. Without ATP, the normal ionic gradients across cell membranes cannot be maintained. Po tassium efflux and sodium influx depolarize the cells, allowing calcium entry into the cells down the large concentration gradient. The membrane pumps for removing calcium are ineffective because they are ATP dependent. An increase in intracellular cal cium in vascular smooth muscle cells activates myosin light chain kinase; this in turn catalyzes the phosphorylation of myosin, which increases the actin-myosin interaction, resulting in contraction and then vasoconstriction (Vanhoutte, 1985 a Normal values from Newberg et al. (1985) . b Significantly different from normal.
The smooth muscle of the cerebral resistance vessels is more dependent on the influx of calcium from the extracellular fluid for contraction than are other blood vessels (McCalden and Bevan, 1981) .
By blocking the calcium channel in the vascular smooth muscle, nimodipine might prevent the in flux of calcium following complete ischemia and thereby prevent the postischemic hypoperfusion state. Nimodipine has been shown to block thc va soconstrictor response of cerebral arteries to sero tonin, norepinephrine, histamine, and potassium both in vitro (Brandt et aI. , 1981) and in vivo (Haws and Heistad, 1984) . In addition, it has been shown to inhibit vasoconstriction of the basilar artery pro duced by carbocyclic thromboxane, a stable analog of the unstable thromboxane A2 (Towart and Perz born, 198 I). The ability of nimodipine to reverse the cerebral vasoconstriction even when given up to I h post ischemia appears to be unique. The mul tiple actions of nimodipine in preventing calcium influx into the cell to inhibit contraction coupling and the actions of several endogenous vasocon strictors may explain its ability to ameliorate or rc verse severe vasospasm. Its ability to dilate cere bral vessels in pathologic states is not unique to the postischemic hypoperfusion state. It has also been shown to prevent or reverse cerebral artery spasm accompanying subarachnoid hemorrhage (Allen, 1985) and to increase CBF following acute stroke (Gelmers, 1985) .
Nimodipine did not affect CMR02. Following a transient 30-min decrease in oxygen metabolism, CMR02 returned toward normal in all groups (Fig.   3 ), remaining � 78% of control. These findings are similar to those in our two previous nimodipine studies (Steen et aI., 1983 (Steen et aI., , 1984 . The fact that the CMR02 remains lower than control levels can be only partially explained by the increased CMR02 measured during the control period due to the N20 analgesia during the preischemic period. CMR02 measured in dogs under 70% N20 (as in this study) is II % higher than that measured in dogs breathing J Cereb Blood Flo\!' Me/llh. Vol. 6. No. 3. 1986 70% N2 and 30% O2 ).
In conclusion, delayed treatment with nimodi pine appears to prevent or reverse severe hypoper fusion following complete cerebral ischemia. If prolonged hypoperfusion does contribute to the ul timate neurologic damage following complete cere bral ischemia, then even delayed treatment of such hypoperfusion may affect neurologic outcome.
